to determine whether it is a safe and efficacious approach for lowering A␤ in man. To this end, we have Upregulation of proteases that degrade A␤ thus represents a novel therapeutic approach to lowering examined the consequences in mice of enhancing the activities of either IDE or NEP, the two A␤-degrading steady-state A␤ levels, but the consequences of sustained upregulation in vivo have not been studied. Here proteases that have received the most experimental confirmation. Our results show that chronically upregulating we show that transgenic overexpression of insulindegrading enzyme (IDE) or neprilysin (NEP) in neurons the activity of either protease in neurons results in striking decreases in brain A␤ levels, plaque formation and significantly reduces brain A␤ levels, retards or completely prevents amyloid plaque formation and its asits associated cytopathology, and premature death in APP transgenic mice, in the absence of detectable adsociated cytopathology, and rescues the premature lethality present in amyloid precursor protein (APP) verse effects. transgenic mice. Our findings demonstrate that chronic upregulation of A␤-degrading proteases represents Results an efficacious therapeutic approach to combating Alzheimer-type pathology in vivo.
Introduction layed, neuron-specific expression (CaM kinase II; Mayford et al., 1996; Figure 1A ). From among numerous Alzheimer's disease (AD) is the most prevalent example potential founder animals, we obtained two stable of a class of human neurodegenerative disorders that mouse lines, one that expressed ‫-2ف‬fold IDE (2xIDE) and involves progressive accumulation of misfolded, ␤ sheetanother that expressed ‫-8ف‬fold NEP (8xNEP), relative rich proteins (Caughey and Lansbury, 2003) . Genetic to nontransgenic littermate controls, as determined by mutations that increase the production or stability of quantitative Western blotting and protease activity these proteins result in accelerated and severe forms assays (see below). The higher-fold increase in protease of the disorders, signifying that accumulation of the proexpression attained in the 8xNEP transgenic line is likely teins in the nervous system can actually cause the redue to lower basal (endogenous) levels of brain NEP spective clinical syndromes. In the case of AD, the than IDE and also to more efficient translation of the mechanisms of A␤ production, including the effects of NEP transgene, because the human NEP cDNA contains causative mutations in the APP and presenilin genes, a better Kozak consensus sequence for translation initihave received great attention, whereas far less is known ation than does the IDE cDNA (Kozak, 1986 ). Consistent about how A␤ is normally degraded and cleared (Selkoe, with the latter explanation, the 2xIDE transgenic line 2001). Among the proteases that have been found to be was found to express ‫4ف‬ times more transgene RNA capable of degrading A␤ in vitro, several (IDE, NEP, than the 8xNEP transgenic mice, as judged by real-time and endothelin-converting enzyme-1 and -2) have been RT-PCR using primers common to the two transgenes confirmed via genetic deletion in mice to contribute to (data not shown). the regulation of endogenous brain A␤ levels in vivo To examine the consequences for A␤ accumulation and amyloid plaque formation, the 2xIDE and 8xNEP transgenic mice were each crossed to transgenic mice *Correspondence:dselkoe@rics.bwh.harvard.edu overexpressing high levels of human APP harboring founded by the fact that the vast majority of A␤-degrading activity in these brain membrane samples is attributable both the KM670/671NL ("Swedish") and the V717F ("Indiana") AD-causing mutations (Mucke et al., 2000;  to IDE. We therefore used the more selective and wellcharacterized NEP substrate DAGPNG (Florentin et al., Figure 1A ). The degree of overexpression of each protease in the crossed mice was determined by quantitative 1984) and determined that NEP activity was increased ‫%007ف‬ in the 8xNEPϩAPP mice relative to controls Western analysis on amino acid-analyzed brain membrane fractions ( Figure 1B ). Interestingly, a small but ( Figure 1D ). These functional assays thus closely reflect the relative increases in the respective proteins we obstatistically significant decrease in endogenous IDE levels was observed in the 8xNEPϩAPP transgenic mice served by Western blotting. APP Swe/Ind single transgenic mice raised in our colony (normalized densitometry values of 0.70 Ϯ 0.15 in the 8xNEPϩAPP transgenic mice versus 1.00 Ϯ 0.04 in APP suffer an abnormally high rate of premature death (Յ6 months) that cosegregates with the APP transgene. transgenic controls; p Ͻ 0.05 by two-tailed Student's t test), and a similar, albeit nonsignificant, decrease in Such premature lethality is not unique to APP Swe/Ind mice, having been observed in other APP transgenic mouse NEP levels was present in some IDE transgenic mice ( Figure 1B) . These results raise the possibility of crossmodels (e.g., Hsiao et al., 1995; D. Games and D. Schenk, personal communication). Remarkably, the incidence of regulation between the two proteases, perhaps mediated by a common substrate. Importantly, the levels of premature death at 6 months of age was significantly attenuated in the 2xIDEϩAPP and the 8xNEPϩAPP full-length APP and APP carboxy-terminal fragments (C83 and C99) were unchanged in the 2xIDEϩAPP and transgenic mice relative to their APP transgenic littermate controls ( Figure 1E ). The fact that this effect 8xNEPϩAPP transgenic mice, excluding a detectable effect of these proteases on the ␣-, ␤-, and ␥-secretase was observed following upregulation of two different A␤-degrading proteases that otherwise are not believed processing steps ( Figure 1B) .
Using a well-characterized iodinated A␤ degradation to have substrates in common strongly suggests that progressive A␤ build-up is responsible for the enhanced assay, we confirmed that the 2xIDEϩAPP mice had an ‫%001ف‬ increase in insulin-inhibitable A␤-degrading camortality observed in our APP transgenic mice. Moreover, the fact that premature death can occur as early pacity in isolated, washed brain membranes compared to their APP transgenic littermates ( Figure 1C ). 8xNEPϩ-as 3 months of age ( Figure 1E ), well prior to plaque deposition (see also Hsiao et al., 1995), implies that the APP mice also exhibited a large increase in thiorphaninhibitable A␤ degradation using this assay (data not responsible A␤ species are soluble. To determine the effects of protease overexpression shown), although accurate quantification was con- 
